Selenium (Se) is
an essential trace element in animals; however,
the element can become highly toxic in excess amounts beyond the nutritional
level. Although Se is mainly excreted into urine as a selenosugar
within the nutritional level, excess amounts of Se are transformed
as an alternative urinary metabolite, trimethylselenonium ion (TMSe).
Se methylation appears to be an important metabolic process for the
detoxification of excess Se; however, the biochemical mechanisms underlying
the Se methylation have not been elucidated. In this study, we evaluated
biochemical characteristics of two human methyltransferases for Se
methylation, thiopurine S-methyltransferase (TPMT)
and indolethylamine N-methyltransferase (INMT). The
first methylation of Se, i.e., a nonmethylated to a monomethylated
form, was specifically driven by TPMT, and INMT specifically mediated
the third methylation, i.e., dimethylated to trimethylated form. The
second methylation, i.e., a monomethylated to dimethylated form, was
driven by either TPMT or INMT. Exogenous expression of TPMT, but not
INMT, ameliorated the cytotoxicity of inorganic nonmethylated selenium
salt, suggesting that only TPMT gave the cellular resistance against
selenite exposure. TPMT was ubiquitously expressed in most mouse tissues
and preferably expressed in the liver and kidneys, while INMT was
specifically expressed in the lung and supplementally expressed in
the liver and kidneys. Our results revealed that both TPMT and INMT
cooperatively contributed to the TMSe production, enabling urinary
excretion of Se and maintenance of homeostasis of this essential yet
highly toxic trace element. Thus, TPMT and INMT can be recognized
as selenium methyltransferases as a synonym.